Head-to-head comparison of an intradermal and a virosome influenza vaccine in patients over the age of 60: evaluation of immunogenicity, cross-protection, safety and tolerability.
about
Antibody responses to intradermal or intramuscular MF59-adjuvanted influenza vaccines as evaluated in elderly institutionalized volunteers during a season of partial mismatching between vaccine and circulating A(H3N2) strainsFast vaccine design and development based on correlates of protection (COPs).Immunogenicity of intramuscular MF59-adjuvanted and intradermal administered influenza enhanced vaccines in subjects aged over 60: A literature review.Particle-based platforms for malaria vaccines.Nine μg intradermal influenza vaccine and 15 μg intramuscular influenza vaccine induce similar cellular and humoral immune responses in adults.Vaccine strategies to enhance immune responses in the aged.Fluzone® intra-dermal (Intanza®/Istivac® Intra-dermal): An updated overview.Immunogenicity, safety and tolerability of intradermal influenza vaccines.Influenza vaccination in the elderly.Immunogenicity and Safety of Intradermal Influenza Vaccine in the Elderly: A Meta-Analysis of Randomized Controlled Trials.Influenza immunization in hemodialyzed or kidney transplanted adolescents and young adults.Enhancing tumor specific immune responses by transcutaneous vaccination.
P2860
Q33655279-CF0F7C73-53F1-4DDB-8A76-43177B82B363Q34291098-693FB69B-A105-411E-A89A-D03DBF215A80Q35887679-8DF6A6C4-4D9F-40B6-9410-E3108D51833EQ36396040-B01E510C-3F93-4FB6-BE00-5D05804A31A9Q37159662-803CB79B-7553-47E2-9119-432E7FCC2046Q37179398-66D273E1-9D17-4434-B40E-775126134F4EQ37375954-FC987471-8699-4D79-AC3C-324109CC44B0Q39366321-48C4EAD5-01E9-442D-B8CD-00EB0E586E68Q40134515-2E75CCAE-AE1F-4FA1-804C-0173C3F89AEEQ41255574-ED8D0B29-383D-422F-9EA0-EDDBFBE34C98Q42209552-BE5817DF-099E-45F8-BAD4-10F4E9102EF9Q49932505-7208327B-22F8-4024-9907-17E64CD31E4F
P2860
Head-to-head comparison of an intradermal and a virosome influenza vaccine in patients over the age of 60: evaluation of immunogenicity, cross-protection, safety and tolerability.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 07 January 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Head-to-head comparison of an ...... tion, safety and tolerability.
@en
Head-to-head comparison of an ...... tion, safety and tolerability.
@nl
type
label
Head-to-head comparison of an ...... tion, safety and tolerability.
@en
Head-to-head comparison of an ...... tion, safety and tolerability.
@nl
prefLabel
Head-to-head comparison of an ...... tion, safety and tolerability.
@en
Head-to-head comparison of an ...... tion, safety and tolerability.
@nl
P2093
P2860
P356
P1476
Head-to-head comparison of an ...... tion, safety and tolerability.
@en
P2093
Andrea Orsi
Daniela de Florentiis
Emanuela Rappazzo
Filippo Ansaldi
Giancarlo Icardi
Martina Coppelli
Paolo Durando
Valentina Parodi
P2860
P304
P356
10.4161/HV.23240
P577
2013-01-07T00:00:00Z